单中心立体定向体部放疗治疗非小细胞肺癌的回顾性长期随访研究:晚期局部复发发生率
该单中心回顾性研究分析了1998年4月至2014年8月间接受立体定向体部放疗(等中心处方48 Gy分4次)的216例患者共230个肿瘤,中位随访3.9年,5年局部复发率为19%(95%CI 14%-25%),5年后仍观察到7例晚期局部复发。多因素分析显示较大肿瘤尺寸、鳞状细胞组织学(相比腺癌)及使用腹部压迫进行呼吸运动管理是局部复发的独立不良预后因素。作者认为晚期局部复发并不少见,需要仔细随访,尤其是腺癌患者。
要点
- 5年局部复发率为19%(95%CI 14%-25%),49例(21%)发生局部复发,中位至局部复发时间腺癌2.1年、鳞癌1.3年。
- 73个随访超过5年的肿瘤中观察到7例晚期局部复发,组织学为腺癌3例、鳞癌2例、未知2例。
- 多因素分析显示较大肿瘤尺寸、鳞状细胞组织学(相比腺癌)及使用腹部压迫是局部复发的独立不良预后因素。
核心结论
- 长期随访数据显示晚期局部复发并不少见,作者认为需要仔细随访,尤其是腺癌患者。
研究设计与样本
- 单中心回顾性长期随访研究,纳入1998年4月至2014年8月间接受立体定向体部放疗(等中心处方48 Gy分4次)的原发或复发非小细胞肺癌患者,肿瘤<3 cm,随访>6个月,共分析216例患者和230个肿瘤。
主要发现
- 无局部复发肿瘤的中位随访时间为3.9年,局部复发病例粗数为49例(21%)。
- 5年局部复发 actuarial 率为19%(95%CI 14%-25%)。
- 各时间段局部复发病例数:第1年10例,第2年17例,第3年9例,第4年3例,第5年3例,5年后7例。
- 73个随访超过5年的肿瘤中观察到7例晚期局部复发,组织学为腺癌3例、鳞状细胞癌2例、未知2例(其中1例未知病例在挽救手术后证实为腺癌)。
- 至局部复发的中位时间:腺癌2.1年(四分位距1.5-4.2年),鳞状细胞癌1.3年(四分位距1.0-2.3年)。
临床怎么用
- 作者认为立体定向体部放疗后需要仔细随访,尤其是腺癌患者。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To assess the local recurrence (LR) rate and timing after stereotactic body radiation therapy (SBRT) for non-small cell lung cancer using long-term follow-up data from a single institution. METHODS AND MATERIALS: Patients with primary or recurrent non-small cell lung cancer with or without pathologic verification, with tumors <3 cm, treated with SBRT (isocenter prescription of 48 Gy in 4 fractions) between April 1998 and August 2014, and with >6 months' follow-up were eligible. The LR rate was calculated by the cumulative incidence function, accounting for death as a competing risk. Univariate and multivariate analyses were performed to identify prognostic factors for LR. RESULTS: A total of 216 patients and 230 tumors were analyzed. The median follow-up time of tumors without LR was 3.9 years, and the crude number of LR cases was 49 (21%). The actuarial rate of LR was 19% (95% confidence interval, 14%-25%) at 5 years. The number of LR cases in each period was 10 in year 1, 17 in year 2, 9 in year 3, 3 in year 4, 3 in year 5, and 7 after 5 years. Among 73 tumors with >5 years' follow-up, we observed 7 late LRs. The tumor histology of these late LRs was adenocarcinoma in 3, squamous cell carcinoma in 2, and unknown in 2 (1 of the unknown cases was confirmed as adenocarcinoma following salvage surgery). The median time to LR was 2.1 years (interquartile range, 1.5-4.2 years) for adenocarcinoma compared with 1.3 years (interquartile range, 1.0-2.3 years) for squamous cell carcinoma. Multivariate analysis revealed that larger tumor size, squamous cell histology compared with adenocarcinoma, and use of abdominal compression for respiratory motion management were independent negative prognostic factors for LR. CONCLUSIONS: Long-term follow-up data demonstrated that late LR was not uncommon and that careful follow-up after SBRT is needed, especially in patients with adenocarcinoma.
引用
- Shintani T, Matsuo Y, Iizuka Y, et al. A Retrospective Long-term Follow-up Study of Stereotactic Body Radiation Therapy for Non-Small Cell Lung Cancer From a Single Institution: Incidence of Late Local Recurrence. Int J Radiat Oncol Biol Phys. 2018. PMID: 29722662. doi:10.1016/j.ijrobp.2018.01.050
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。